Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Immunoglobulin G (IgG) mediates pro- and anti-inflammatory activities through the engagement of its Fc fragment (Fc) with distinct Fcg receptors (FcgRs). One class of Fc-FcgR interactions generates pro-inflammatory effects of immune complexes and cytotoxic antibodies. In contrast, therapeutic intravenous gamma globulin and its Fc fragments are anti-inflammatory. We show here that these distinct properties of the IgG Fc result from differential sialylation of the Fc core polysaccharide. IgG acquires anti-inflammatory properties upon Fc sialylation, which is reduced upon the induction of an antigen-specific immune response. This differential sialylation may provide a switch from innate anti-inflammatory activity in the steady state to generating adaptive pro-inflammatory effects upon antigenic challenge.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CREB activation can promote the expression of anti-inflammatory genes while inhibiting inflammatory genes.294,295”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [295]
Citations
Cites
Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD
Imbach, P., d'APUZZO, V., Hirt, A., Rossi, E., Vest, M., Barandun, S., Baumgartner, C., Morell, A., Schöni, M., & Wagner, H. P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92400-4 · Cited by 1,666
Parekh, R. B., Dwek, R. A., Sutton, B. J., Fernandes, D. L., Leung, A., Stanworth, D., Rademacher, T. W., Mizuochi, T., Taniguchi, T., Matsuta, K., et al. (1985) · Nature · doi:10.1038/316452a0 · Cited by 1,170
Fcγ Receptors: Old Friends and New Family Members
Nimmerjahn, F., & Ravetch, J. V. (2006) · Immunity · doi:10.1016/j.immuni.2005.11.010 · Cited by 1,072
Self-citationAnti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor
Samuelsson, A., Towers, T. L., & Ravetch, J. V. (2001) · Science · doi:10.1126/science.291.5503.484 · Cited by 1,053
Self-citationDivergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding
Nimmerjahn, F., & Ravetch, J. V. (2005) · Science · doi:10.1126/science.1118948 · Cited by 1,037
Self-citationArthritis Critically Dependent on Innate Immune System Players
Ji, H., Ohmura, K., Mahmood, U., Lee, D. M., Hofhuis, F. M. A., Boackle, S. A., Takahashi, K., Holers, V. M., Walport, M., Gerard, C., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00275-3 · Cited by 693
FcγRIV: A Novel FcR with Distinct IgG Subclass Specificity
Nimmerjahn, F., Bruhns, P., Horiuchi, K., & Ravetch, J. V. (2005) · Immunity · doi:10.1016/j.immuni.2005.05.010 · Cited by 660
Self-citationManipulating the Immune System with Immune Globulin
Oates, J. A., Wood, A. J. J., & Dwyer, J. M. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201093260206 · Cited by 648
Effect of glycosylation on antibody function: implications for genetic engineering
Wright, A., & Morrison, S. L. (1997) · Trends in Biotechnology · doi:10.1016/s0167-7799(96)10062-7 · Cited by 312
Research works printed but not linked: 1
- M. Holland et al., Biochim. Biophys. Acta1760, 669 (2005).
Cited by
Items 401–500 of 1,003
Mastrocola, R., Collotta, D., Gaudioso, G., Berre, M. L., Cento, A. S., Alves, G. F., Chiazza, F., Verta, R., Bertocchi, I., Manig, F., et al. (2020) · Nutrients · doi:10.3390/nu12092497 · Cited by 79
Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV
Giron, L. B., Palmer, C. S., Liu, Q., Yin, X., Papasavvas, E., Sharaf, R., Etemad, B., Damra, M., Goldman, A. R., Tang, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24077-w · Cited by 82
The importance of IgG glycosylation—What did we learn after analyzing over 100,000 individuals
Krištić, J., & Lauc, G. (2024) · Immunological Reviews · doi:10.1111/imr.13407 · Cited by 101
Total Synthesis of the 2,6-Sialylated Immunoglobulin G Glycopeptide Fragment in Homogeneous Form
Wang, P., Zhu, J., Yuan, Y., & Danishefsky, S. J. (2009) · Journal of the American Chemical Society · doi:10.1021/ja907136d · Cited by 73
The carbohydrate switch between pathogenic and immunosuppressive antigen‐specific antibodies
Collin, M., & Ehlers, M. (2013) · Experimental Dermatology · doi:10.1111/exd.12171 · Cited by 73
Considerations for the development of therapeutic monoclonal antibodies
Swann, P. G., Tolnay, M., Muthukkumar, S., Shapiro, M. A., Rellahan, B. L., & Clouse, K. A. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.05.013 · Cited by 78
Advances in diagnosing and managing antibody-mediated rejection
Jordan, S. C., Reinsmoen, N. L., Peng, A., Lai, C.-H., Cao, K., Villicana, R., Toyoda, M., Kahwaji, J. M., & Vo, A. A. (2010) · Pediatric Nephrology · doi:10.1007/s00467-009-1386-4 · Cited by 73
Small-molecule control of antibody N-glycosylation in engineered mammalian cells
Chang, M. M., Gaidukov, L., Jung, G., Tseng, W. A., Scarcelli, J. J., Cornell, R. J., Marshall, J. K., Lyles, J. L., Sakorafas, P., Chu, A. A., et al. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0288-4 · Cited by 78
Finding the sweet spot: glycosylation mediated regulation of intestinal inflammation
Brazil, J. C., & Parkos, C. A. (2021) · Mucosal Immunology · doi:10.1038/s41385-021-00466-8 · Cited by 75
Bartsch, Y. C., Rahmöller, J., Mertes, M. M. M., Eiglmeier, S., Lorenz, F. K. M., Stoehr, A. D., Braumann, D., Lorenz, A., Winkler, A., Lilienthal, G., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01183 · Cited by 75
Analytical and Functional Aspects of Antibody Sialylation
Stadlmann, J., Pabst, M., & Altmann, F. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9409-2 · Cited by 71
Immunotherapy of Malignant Disease with Tumor Antigen–Specific Monoclonal Antibodies
Campoli, M. R., Ferris, R. L., Ferrone, S., & Wang, X. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2345 · Cited by 84
Glycosylated Biotherapeutics: Immunological Effects of N-Glycolylneuraminic Acid
Yehuda, S., & Padler-Karavani, V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00021 · Cited by 71
Intravenous Immunoglobulin: Mechanism of Action in Autoimmune and Inflammatory Conditions
Bayry, J., Ahmed, E. A., Rivero, D. T., Vonniessen, N., Genest, G., Cohen, C. G., Dembele, M., Kaveri, S. V., & Mazer, B. D. (2023) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.04.002 · Cited by 82
Alteration of the N‐glycome of bovine milk glycoproteins during early lactation
Takimori, S., Shimaoka, H., Furukawa, J., Yamashita, T., Amano, M., Fujitani, N., Takegawa, Y., Hammarström, L. L. G., Kacskovıcs, I., Shinohara, Y., et al. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08299.x · Cited by 72
Allhorn, M., Briceño, J. G., Baudino, L., Lood, C., Olsson, M. L., Izui, S., & Collin, M. (2010) · Blood · doi:10.1182/blood-2009-08-239020 · Cited by 71
Proteolytic Shedding of ST6Gal-I by BACE1 Regulates the Glycosylation and Function of α4β1 Integrins
Woodard-Grice, A. V., McBrayer, A. C., Wakefield, J. K., Zhuo, Y., & Bellis, S. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800836200 · Cited by 71
Huang, W., Yang, Q., Umekawa, M., Yamamoto, K., & Wang, L. (2010) · ChemBioChem · doi:10.1002/cbic.201000242 · Cited by 78
Homann, A., Schramm, G., & Jappe, U. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.04.019 · Cited by 75
Glycoengineering in CHO cells: advances in systems biology
Tejwani, V., Andersen, M. R., Nam, J. H., & Sharfstein, S. T. (2018) · Biotechnology Journal · doi:10.1002/biot.201700234 · Cited by 70
Chemoenzymatic Fc Glycosylation via Engineered Aldehyde Tags
Smith, E. L., Giddens, J. P., Iavarone, A. T., Godula, K., Wang, L., & Bertozzi, C. R. (2014) · Bioconjugate Chemistry · doi:10.1021/bc500061s · Cited by 85
Ortiz, D. F., Lansing, J. C., Rutitzky, L., Kurtagic, E., Prod’homme, T., Choudhury, A., Washburn, N., Bhatnagar, N., Beneduce, C., Holte, K., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf9418 · Cited by 67
Self-citationExtensive weight loss reduces glycan age by altering IgG N-glycosylation
Greto, V., Cvetko, A., Štambuk, T., Dempster, N. J., Kifer, D., Deriš, H., Cindrić, A., Vučković, F., Falchi, M., Gillies, R. S., et al. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00816-3 · Cited by 73
Kaveri, S. V., Lacroix‐Desmazes, S., & Bayry, J. (2008) · New England Journal of Medicine · doi:10.1056/nejmcibr0803649 · Cited by 73
Profiling and genetic control of the murine immunoglobulin G glycome
Krištić, J., Zaytseva, O. O., Ram, R., Nguyen, Q., Novokmet, M., Vučković, F., Vilaj, M. Ć., Trbojević‐Akmačić, I., Pezer, M., Davern, K. M., et al. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0034-3 · Cited by 73
Ramakrishna, C., Newo, A. N. S., Shen, Y.-W., & Cantin, E. M. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002071 · Cited by 68
Assessment of structural and functional similarity of biosimilar products: Rituximab as a case study
Nupur, N., Chhabra, N., Dash, R., & Rathore, A. S. (2017) · mAbs · doi:10.1080/19420862.2017.1402996 · Cited by 73
Deyev, S. M., Lebedenko, E. N., Petrovskaya, L. E., Dolgikh, D. A., Gabibov, A. G., & Kirpichnikov, M. P. (2014) · Russian Chemical Reviews · doi:10.1070/rcr4459 · Cited by 78
Targeting the Fc receptor in autoimmune disease
Li, X., & Kimberly, R. P. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.877891 · Cited by 73
Crispin, M., Bowden, T. A., Coles, C. H., Harlos, K., Aricescu, A. R., Harvey, D. J., Stuart, D. I., & Jones, E. Y. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.02.033 · Cited by 72
Mutation of Y407 in the CH3 domain dramatically alters glycosylation and structure of human IgG
Rose, R. J., van Berkel, P. H. C., van den Bremer, E. T. J., Labrijn, A. F., Vink, T., Schuurman, J., Heck, A. J. R., & Parren, P. W. H. I. (2013) · mAbs · doi:10.4161/mabs.23532 · Cited by 67
Wenink, M. H., Santegoets, K. C. M., Roelofs, M. F., Huijbens, R. J. F., Koenen, H. J. P. M., van Beek, R., Joosten, I., Meyer‐Wentrup, F. A. G., Mathsson, L., Rönnelid, J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900153 · Cited by 72
Boon, L., Ugarte-Berzal, E., Vandooren, J., & Opdenakker, G. (2016) · Biochemical Journal · doi:10.1042/bj20151154 · Cited by 74
Boeggeman, E. E., Ramakrishnan, B., Kilgore, C., Khidekel, N., Hsieh‐Wilson, L. C., Simpson, J. T., & Qasba, P. K. (2007) · Bioconjugate Chemistry · doi:10.1021/bc060341n · Cited by 69
Customized protein glycosylation to improve biopharmaceutical function and targeting
Van Landuyt, L., Lonigro, C., Meuris, L., & Callewaert, N. (2019) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2018.11.017 · Cited by 66
Liu, X., Cao, W., & Li, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01660 · Cited by 78
Chavele, K.-M., Martínez‐Pomares, L., Jan Domin, Y., Pemberton, S., Haslam, S. M., Dell, A., Cook, H. T., Pusey, C. D., Gordon, S., & Salama, A. D. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41560 · Cited by 66
The association between galactosylation of immunoglobulin G and body mass index
Perković, M. N., Pučić‐Baković, M., Krištić, J., Novokmet, M., Huffman, J. E., Vitart, V., Hayward, C., Rudan, I., Wilson, J. F., Campbell, H. J., et al. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.08.014 · Cited by 74
Ogata, S., Shimizu, C., Franco, A., Touma, R., Kanegaye, J. T., Choudhury, B. P., Naidu, N. N., Kanda, Y., Hoang, L. T., Hibberd, M. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081448 · Cited by 66
Sweet and sour: the impact of sugars on disease
Alavi, A., & Axford, J. S. (2008) · Rheumatology · doi:10.1093/rheumatology/ken081 · Cited by 78
Improving Immunotherapy Through Glycodesign
Buettner, M. J., Shah, S. R., Saeui, C. T., Ariss, R., & Yarema, K. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02485 · Cited by 70
Structural characterization of GASDALIE Fc bound to the activating Fc receptor FcγRIIIa
Ahmed, A. A., Keremane, S., Vielmetter, J., & Björkman, P. J. (2016) · Journal of Structural Biology · doi:10.1016/j.jsb.2016.02.001 · Cited by 75
The efficacy of deep learning based LSTM model in forecasting the outbreak of contagious diseases
Absar, N., Uddin, N., Khandaker, M. U., & Ullah, H. (2021) · Infectious Disease Modelling · doi:10.1016/j.idm.2021.12.005 · Cited by 88
Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19
Pongrácz, T., Nouta, J., Wang, W., van Meijgaarden, K. E., Linty, F., Vidarsson, G., Joosten, S. A., Ottenhoff, T. H. M., Hokke, C. H., de Vries, J. J. C., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103957 · Cited by 75
Inforzato, A., Reading, P. C., Barbati, E., Bottazzi, B., Garlanda, C., & Mantovani, A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00407 · Cited by 74
Dugast, A., Chan, Y. N., Hoffner, M., Licht, A. F., Nkolola, J. P., Li, H., Streeck, H., Suscovich, T. J., Ghebremichael, M. S., Ackerman, M. E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097229 · Cited by 70
Activating and inhibitory FcγRs in autoimmune disorders
Nimmerjahn, F. (2006) · Springer Seminars in Immunopathology · doi:10.1007/s00281-006-0052-1 · Cited by 76
Self-citationGlycosylation Profile of IgG in Moderate Kidney Dysfunction
Barrios, C. P., Zierer, J., Gudelj, I., Štambuk, J., Ugrina, I., Rodríguez, E., Soler, M. J., Štambuk, T., Šimurina, M., Keser, T., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015010109 · Cited by 71
New paradigms for functional HIV-specific nonneutralizing antibodies
Forthal, D. N., Hope, T. J., & Alter, G. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328363d486 · Cited by 70
Glycans as a key factor in self and nonself discrimination: impact on the breach of immune tolerance
Alves, I., Fernandes, Â., Santos‐Pereira, B., Azevedo, C. M., & Pinho, S. S. (2022) · FEBS Letters · doi:10.1002/1873-3468.14347 · Cited by 66
Strategies for Glycoengineering Therapeutic Proteins
Dammen-Brower, K., Epler, P., Zhu, S., Bernstein, Z. J., Stabach, P. R., Braddock, D. T., Spangler, J. B., & Yarema, K. J. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.863118 · Cited by 62
Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapies
Rocamora, F., Peralta, A. G., Shin, S., Sorrentino, J., Wu, M. Y. M., Toth, E. A., Fuerst, T. R., & Lewis, N. E. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108206 · Cited by 67
Gaifem, J., Rodrigues, C. S., Petralia, F., Alves, I., Leite-Gomes, E., Cavadas, B., Dias, A. M., Moreira-Barbosa, C., Revés, J., Laird, R. M., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01916-8 · Cited by 76
Fucosylated Glycoproteins as Markers of Liver Disease
Mehta, A. S., & Block, T. M. (2008) · Disease Markers · doi:10.1155/2008/264594 · Cited by 73
Intravenous immunoglobulin therapy for autoimmune diseases
Arnson, Y., Shoenfeld, Y., & Amital, H. (2009) · Autoimmunity · doi:10.1080/08916930902785363 · Cited by 64
Analytical glycobiology at high sensitivity: current approaches and directions
Novotny, M. V., Alley, W. R., & Mann, B. F. (2013) · Glycoconjugate Journal · doi:10.1007/s10719-012-9444-8 · Cited by 64
Intravenous immunoglobulins induce potentially synergistic immunomodulations in autoimmune disorders
Imbach, P. A., Lazarus, A. H., & Kühne, T. (2009) · Vox Sanguinis · doi:10.1111/j.1423-0410.2009.01264.x · Cited by 64
Sesărman, A., Sitaru, A. G., Olaru, F., Zillikens, D., & Sitaru, C. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0366-7 · Cited by 64
Maternal Pre-Pregnancy Obesity Is Associated with Altered Placental Transcriptome
Altmäe, S., Segura, M. T., Esteban, F. J., Bartel, S., Brandi-Blanco, P., Irmler, M., Beckers, J., Demmelmair, H., López‐Sabater, M. C., Koletzko, B. V., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169223 · Cited by 75
Gurevich, M., Gritzman, T., Orbach, R., Tuller, T., Feldman, A., & Achiron, A. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.02.010 · Cited by 63
Mechanisms of action of intravenous immunoglobulins
Baerenwaldt, A., Biburger, M., & Nimmerjahn, F. (2010) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.9 · Cited by 68
Self-citationGlycosylation of monoclonal antibody products: Current status and future prospects
Batra, J., & Rathore, A. S. (2016) · Biotechnology Progress · doi:10.1002/btpr.2366 · Cited by 63
Dent, M. W., Hurtado, J., Paul, A. M., Sun, H., Lai, H., Yang, M., Esqueda, A., Bai, F., Steinkellner, H., & Chen, Q. (2016) · Journal of General Virology · doi:10.1099/jgv.0.000635 · Cited by 63
Fcγ receptor expression on splenic macrophages in adult immune thrombocytopenia
Audia, S., Santegoets, K. C. M., Laarhoven, A. G., Vidarsson, G., Facy, O., Ortega‐Deballon, P., Samson, M., Janikashvili, N., Saas, P., Bonnotte, B., et al. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.12935 · Cited by 63
Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering
Yu, X., Marshall, M. J. E., Cragg, M. S., & Crispin, M. (2017) · BioDrugs · doi:10.1007/s40259-017-0223-8 · Cited by 71
N-glycans as functional effectors of genetic and epigenetic disease risk
Štambuk, T., Klasić, M., Zoldoš, V., & Lauc, G. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100891 · Cited by 70
Bartsch, Y. C., Eschweiler, S., Leliavski, A., Lunding, H. B., Wagt, S., Petry, J., Lilienthal, G., Rahmöller, J., de Haan, N., Hölscher, A., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.04.059 · Cited by 72
Seymour, B. J., Trent, B. J., Allen, B. E., Berlinberg, A. J., Tangchittsumran, J., Jubair, W. K., Chriswell, M. E., Liu, S., Ornelas, A., Stahly, A., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci167671 · Cited by 73
Wieland, A., Shashidharamurthy, R., Kamphorst, A. O., Han, J., Aubert, R. D., Choudhury, B., Stowell, S. R., Lee, J., Punkosdy, G. A., Shlomchik, M. J., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.01.009 · Cited by 65
The protective role of immunoglobulins in fungal infections and inflammation
Elluru, S. R., Kaveri, S. V., & Bayry, J. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0466-0 · Cited by 67
Modulation of antibody effector function
Desjarlais, J. R., & Lazar, G. A. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.03.018 · Cited by 64
Fc receptors: Cell activators of antibody functions
Rosales, C., & Uribe‐Querol, E. (2013) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2013.44a004 · Cited by 76
Enhancing glycoprotein sialylation by targeted gene silencing in mammalian cells
Zhang, M., Koskie, K., Ross, J. S., Kayser, K. J., & Caple, M. V. (2010) · Biotechnology and Bioengineering · doi:10.1002/bit.22633 · Cited by 62
Hershkovitz, O., Jarahian, M., Zilka, A., Bar-Ilan, A., Landau, G., Jivov, S., Tekoah, Y., Glicklis, R., Gallagher, J., Hoffmann, S. C., et al. (2008) · Glycobiology · doi:10.1093/glycob/cwm125 · Cited by 65
Alsughayyir, J., Pettigrew, G. J., & Motallebzadeh, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01639 · Cited by 61
Intravenous immune globulin in hereditary inclusion body myopathy: a pilot study
Sparks, S. E., Rakočević, G., Joe, G. O., Manoli, I., Shrader, J. A., Harris‐Love, M. O., Sonies, B. C., Ciccone, C., Dorward, H. M., Krasnewich, D. M., et al. (2007) · BMC Neurology · doi:10.1186/1471-2377-7-3 · Cited by 68
Monoclonal antibodies — a proven and rapidly expanding therapeutic modality for human diseases
An, Z. (2010) · Protein & Cell · doi:10.1007/s13238-010-0052-8 · Cited by 79
Glycans – the third revolution in evolution
Lauc, G., Krištić, J., & ZoldoÅ¡, V. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00145 · Cited by 76
Fc Glycans Terminated with N-Acetylglucosamine Residues Increase Antibody Resistance to Papain
Raju, T. S., & Scallon, B. J. (2007) · Biotechnology Progress · doi:10.1021/bp070118k · Cited by 76
Reusch, D., Haberger, M., Kailich, T., Heidenreich, A.-K., Kampe, M., Bulau, P., & Wuhrer, M. (2014) · mAbs · doi:10.4161/mabs.26712 · Cited by 61
Structure and Function of Immunoglobulins
Schroeder, H. W., & Greenspan, N. S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.00112-4 · Cited by 63
B cell class switching in intestinal immunity in health and disease
Fleming, A., Castro‐Dopico, T., & Clatworthy, M. R. (2022) · Scandinavian Journal of Immunology · doi:10.1111/sji.13139 · Cited by 68
European Medicines Agency workshop on biosimilar monoclonal antibodies: July 2, 2009, London, UK
Reichert, J. M., Beck, A., & Iyer, H. V. (2009) · mAbs · doi:10.4161/mabs.1.5.9630 · Cited by 61
Bundhoo, A., Paveglio, S. A., Rafti, E., Dhongade, A., Blumberg, R. S., & Matson, A. P. (2015) · Clinical & Experimental Allergy · doi:10.1111/cea.12508 · Cited by 67
van de Bovenkamp, F. S., Derksen, N. I. L., van Breemen, M. J., de Taeye, S. W., Heer, P. O., Sanders, R. W., & Rispens, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00740 · Cited by 60
Wen, C., Guo, Q., Wang, W., Duan, Y., Zhang, L., Li, J., He, S., Chen, W., & Li, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00449 · Cited by 63
Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches
Hasan, A., Al‐Ozairi, E., Albaqsumi, Z., Ahmad, R., & Al‐Mulla, F. (2021) · ImmunoTargets and Therapy · doi:10.2147/itt.s280706 · Cited by 56
Immunoglobulin G N-Glycosylation Signatures in Incident Type 2 Diabetes and Cardiovascular Disease
Birukov, A., Plavša, B., Eichelmann, F., Kuxhaus, O., Hoshi, R. A., Rudman, N., Štambuk, T., Trbojević‐Akmačić, I., Schiborn, C., Morze, J., et al. (2022) · Diabetes Care · doi:10.2337/dc22-0833 · Cited by 66
IgG Fc N-Glycosylation in Guillain–Barré Syndrome Treated with Immunoglobulins
Fokkink, W. R., Selman, M. H. J., Dortland, J. R., Durmuş, B., Kuitwaard, K., Huizinga, R., van Rijs, W., Tio‐Gillen, A. P., van Doorn, P. A., Deelder, A. M., et al. (2014) · Journal of Proteome Research · doi:10.1021/pr401213z · Cited by 65
Substrate Specificity of Cytoplasmic N-Glycosyltransferase
Naegeli, A., Michaud, G., Schubert, M., Lin, C., Lizak, C., Darbre, T., Reymond, J., & Aebi, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.579326 · Cited by 62
IgG-Fc glycoengineering in non-mammalian expression hosts
Loos, A., & Steinkellner, H. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.05.011 · Cited by 66
Lü, Y., Bie, Z., Liu, Y., & Liu, Z. (2012) · The Analyst · doi:10.1039/c2an36048a · Cited by 59
Jain, A., Olsen, H. S., Vyzasatya, R., Burch, E., Sakoda, Y., Mérigeon, E. Y., Cai, L., Lu, C., Tan, M., Tamada, K., et al. (2012) · Arthritis Research & Therapy · doi:10.1186/ar4024 · Cited by 59
Jordan, S. C., Toyoda, M., & Vo, A. A. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.11.10 · Cited by 59
Changes of glycosylation of IgG in rheumatoid arthritis patients treated with methotrexate
Gińdzieńska‐Sieśkiewicz, E., Radziejewska, I., Domysławska, I., Klimiuk, P. A., Sulik, A., Rojewska, J., Porowska, H., & Sierakowski, S. (2016) · Advances in Medical Sciences · doi:10.1016/j.advms.2015.12.009 · Cited by 65
Sialidase inhibitors attenuate pulmonary fibrosis in a mouse model
Karhadkar, T. R., Pilling, D., Cox, N., & Gomer, R. H. (2017) · Scientific Reports · doi:10.1038/s41598-017-15198-8 · Cited by 58
Sialylation of N-Linked Glycans Influences the Immunomodulatory Effects of IgM on T Cells
Colucci, M., Stöckmann, H., Butera, A., Masotti, A., Baldassarre, A., Giorda, E., Petrini, S., Rudd, P. M., Sitia, R., Emma, F., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1402025 · Cited by 63
Mechanisms of immune regulation by IVIG
Ballow, M. C. (2014) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000116 · Cited by 63
Clynes, R. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.09.004 · Cited by 59
Bianco, D. D., Armstrong, P., & Washabau, R. J. (2009) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2009.0358.x · Cited by 58
Metadata
- Authors
- Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V.
- Affiliations
- Rockefeller University (US)
- Corresponding author
- Kaneko, Yoshikatsu
- Nimmerjahn, Falk
- Ravetch, Jeffrey V.
- Venue
- Science
- Published
- 2006-08-04
- Volume
- 313
- Issue
- 5787
- Pages
- 670-673
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2035433348
- Cited by
- 1,754
- References
- 21
- Citations by year
- 2026: 45 · 2025: 55 · 2024: 63 · 2023: 67 · 2022: 77 · 2021: 101 · 2020: 103 · 2019: 93 · 2018: 97 · 2017: 89 · 2016: 96 · 2015: 105 · 2014: 122 · 2013: 113 · 2012: 98
- FWCI
- 71.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IgG, Fc fragment, anti-inflammatory activity, Fc gamma receptor, immune complexes, intravenous immunoglobulin, antigen-specific immune response, innate immunity, adaptive immunity, pro-inflammatory effects
- MeSH terms
- Animals, Antibodies, Monoclonal, Arthritis, Arthritis, Rheumatoid, Glycosylation, Half-Life, Immunoglobulin G, Immunoglobulin Fc Fragments, Inflammation, Mice, Inbred C57BL, Nephritis, Polysaccharides, Receptors, Fc, Sialic Acids, Mice, Inbred NOD, Immunoglobulins, Intravenous, Receptors, IgG, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.